DIALYSIS · CCN 462504

462504 SRS-Provo, LLC

PROVO, UT 84604

DialysisNon-profitIndependent
$1.7M
TOTAL REVENUE
14.8%
OPERATING MARGIN
1 / 5
STAR RATING
12
QUALITY MEASURES
Independent
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$1.7M
Total costs
$1.4M
Operating income (rev − costs)
$246K
Operating margin
14.8%
Total charges
$1.7M
Total treatments
2,735
Dialysis stations
14

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
8325—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.5325—
Fistula Rate
DFC_FISTULA_RATE
59.725—
Five Star Rating
DFC_FIVE_STAR
1——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
017—
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
166.431—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
525—
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2125—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
35.5153—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
12.923—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
34.530—
Standardized ED Visits Ratio
DFC_SEDR
0.7419—